Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Real-World Data & Evidence CollectionPost-Market Safety Registries
Research, Drug Development & Manufacturing

Singapore HSA Adverse Event Reporting

Also known as: Health Sciences Authority Singapore Pharmacovigilance

Singapore Health Sciences Authority adverse-event reporting framework for therapeutic products and clinical trials. Included as core safety-monitoring infrastructure; no dedicated psychedelic public reporting surface identified.

Real-World Data Snapshot

Verified

Verification

Verified

Coverage

1 country

Access Model

Open access

Last Verified

Apr 7, 2026

Methodology

HSA receives and manages adverse-event reports for therapeutic products and trial contexts under national pharmacovigilance and regulatory reporting requirements.

Safety monitoring registriesWeeklySafety surveillance data

Primary Dataset

View HSA Adverse Event Reporting

Source Evidence

2 sources

HSA therapeutic products adverse event reporting

https://www.hsa.gov.sg/therapeutic-products/adverse-events

HSA adverse events reporting in clinical trials

https://www.hsa.gov.sg/clinical-trials/adverse-events

Quick Facts

Website
Visit